Stephen M. Eggan, Ph.D.
Affiliations: | University of Pittsburgh, Pittsburgh, PA, United States |
Area:
Schizophrenia; structure, function and development of prefrontal cortex; effects of cannabis and psychotropic medications on neural circuitryGoogle:
"Stephen Eggan"Mean distance: 15.84 (cluster 17) | S | N | B | C | P |
Parents
Sign in to add mentor| David A. Lewis | grad student | 2007 | University of Pittsburgh | |
| (Cannabinoid CB1 receptor: Role in primate prefrontal circuitry and schizophrenia.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Volk DW, Eggan SM, Horti AG, et al. (2014) Reciprocal alterations in cortical cannabinoid receptor 1 binding relative to protein immunoreactivity and transcript levels in schizophrenia. Schizophrenia Research. 159: 124-9 |
| Curley AA, Eggan SM, Lazarus MS, et al. (2013) Role of glutamic acid decarboxylase 67 in regulating cortical parvalbumin and GABA membrane transporter 1 expression: implications for schizophrenia. Neurobiology of Disease. 50: 179-86 |
| Eggan SM, Lazarus MS, Stoyak SR, et al. (2012) Cortical glutamic acid decarboxylase 67 deficiency results in lower cannabinoid 1 receptor messenger RNA expression: implications for schizophrenia. Biological Psychiatry. 71: 114-9 |
| Volk DW, Eggan SM, Lewis DA. (2010) Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. The American Journal of Psychiatry. 167: 1489-98 |
| Eggan SM, Stoyak SR, Verrico CD, et al. (2010) Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: Comparison of schizophrenia and major depressive disorder. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2060-71 |
| Eggan SM, Melchitzky DS, Sesack SR, et al. (2010) Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience. 169: 1651-61 |
| Eggan SM, Mizoguchi Y, Stoyak SR, et al. (2010) Development of cannabinoid 1 receptor protein and messenger RNA in monkey dorsolateral prefrontal cortex. Cerebral Cortex (New York, N.Y. : 1991). 20: 1164-74 |
| Eggan SM, Hashimoto T, Lewis DA. (2008) Reduced cortical cannabinoid 1 receptor messenger RNA and protein expression in schizophrenia. Archives of General Psychiatry. 65: 772-84 |
| Eggan SM, Lewis DA. (2007) Immunocytochemical distribution of the cannabinoid CB1 receptor in the primate neocortex: a regional and laminar analysis. Cerebral Cortex (New York, N.Y. : 1991). 17: 175-91 |
| Melchitzky DS, Eggan SM, Lewis DA. (2005) Synaptic targets of calretinin-containing axon terminals in macaque monkey prefrontal cortex. Neuroscience. 130: 185-95 |